IRIS
Moroni, Gabriella Luisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.696
NA - Nord America 2.552
SA - Sud America 919
EU - Europa 480
AF - Africa 82
OC - Oceania 7
Totale 7.736
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.417
SG - Singapore 2.266
BR - Brasile 749
VN - Vietnam 467
CN - Cina 456
HK - Hong Kong 171
IT - Italia 134
AR - Argentina 72
MX - Messico 62
GB - Regno Unito 59
IN - India 56
CA - Canada 44
ID - Indonesia 43
BD - Bangladesh 40
DE - Germania 40
EC - Ecuador 37
FR - Francia 30
PL - Polonia 27
FI - Finlandia 26
IE - Irlanda 25
IQ - Iraq 22
PK - Pakistan 22
TR - Turchia 21
UA - Ucraina 21
ZA - Sudafrica 20
JP - Giappone 19
AT - Austria 17
PH - Filippine 17
CO - Colombia 16
MA - Marocco 16
NL - Olanda 16
ES - Italia 14
RU - Federazione Russa 14
CL - Cile 13
SE - Svezia 13
VE - Venezuela 12
SA - Arabia Saudita 11
EG - Egitto 10
MY - Malesia 10
TN - Tunisia 10
AZ - Azerbaigian 9
PY - Paraguay 9
AL - Albania 8
AE - Emirati Arabi Uniti 7
JO - Giordania 7
KE - Kenya 7
CH - Svizzera 6
CR - Costa Rica 6
PA - Panama 6
UZ - Uzbekistan 6
BG - Bulgaria 5
TH - Thailandia 5
UY - Uruguay 5
ET - Etiopia 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
LT - Lituania 4
NZ - Nuova Zelanda 4
OM - Oman 4
BB - Barbados 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
IL - Israele 3
KG - Kirghizistan 3
NG - Nigeria 3
PE - Perù 3
BE - Belgio 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GR - Grecia 2
GY - Guiana 2
HU - Ungheria 2
JM - Giamaica 2
KH - Cambogia 2
KR - Corea 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
MU - Mauritius 2
NI - Nicaragua 2
NP - Nepal 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
GD - Grenada 1
GI - Gibilterra 1
GT - Guatemala 1
HN - Honduras 1
Totale 7.722
Salva come PNG Salva come JPEG
Città #
Singapore 983
Ashburn 513
The Dalles 453
San Jose 418
Hong Kong 170
Ho Chi Minh City 163
Dallas 151
Beijing 148
Shanghai 132
Hanoi 114
New York 72
São Paulo 63
Boardman 43
Mexico City 38
Los Angeles 35
Santa Clara 31
Wilmington 30
Assago 28
Naples 28
Warsaw 27
Helsinki 26
Dublin 23
Haiphong 21
Chandler 20
Rio de Janeiro 20
Da Nang 19
Tokyo 19
Buffalo 17
Montreal 17
Orem 17
Brooklyn 16
Belo Horizonte 14
Boston 14
Fort Worth 14
Rome 14
Brasília 13
Curitiba 13
Hải Dương 13
Johannesburg 13
Biên Hòa 12
Milan 12
Phoenix 12
Quito 12
Jakarta 11
Stockholm 11
Vienna 11
Campinas 10
Chennai 10
Prineville 10
Salvador 10
San Mateo 10
Seattle 10
Baku 9
Can Tho 9
Poplar 9
San Francisco 9
Springfield 9
Baghdad 8
Buenos Aires 8
Council Bluffs 8
Guayaquil 8
Hillsboro 8
Mumbai 8
Nuremberg 8
Reston 8
Thái Bình 8
Amman 7
Amsterdam 7
Chicago 7
Denver 7
Dhaka 7
Porto Alegre 7
Ankara 6
Asunción 6
Atlanta 6
Bắc Ninh 6
Frankfurt am Main 6
Kuala Lumpur 6
London 6
Manchester 6
Nairobi 6
Santiago 6
Sorocaba 6
Campos dos Goytacazes 5
Canoas 5
Castro dei Volsci 5
Hyderabad 5
Istanbul 5
Karachi 5
Kyiv 5
Manaus 5
Manila 5
Montevideo 5
Nova Friburgo 5
Piracicaba 5
Tashkent 5
Thái Nguyên 5
Uberlândia 5
Vitória 5
Zurich 5
Totale 4.414
Salva come PNG Salva come JPEG
Nome #
Acute tubular necrosis following interferon-based therapy for hepatitis C : case study with literature review 118
De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis c (case study and literature review) 82
A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy 76
Kidney Biopsy in Pregnant Women with Glomerular Diseases: Focus on Lupus Nephritis 68
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study 67
Herpes zoster in lupus nephritis: experience on 292 patients followed up for 15 years 65
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis 64
Beyond ISN/RPS Lupus Nephritis Classification: Adding Chronicity Index to Clinical Variables Predicts Kidney Survival 64
A best-practice position statement on pregnancy after kidney transplantation: focusing on the unsolved questions. The Kidney and Pregnancy Study Group of the Italian Society of Nephrology 64
Long-term kidney outcome of patients with rheumatological diseases and antineutrophil cytoplasmic antibody-glomerulonephritis: comparison with a primitive ANCA-glomerulonephritis cohort 63
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 63
ANCA-associated vasculitis with renal involvement 60
Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR Classification Criteria for Granulomatosis with Polyangiitis in Children 59
Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis 59
''Nephritic flares'' are predictors of bad long-term renal outcome in lupus nephritis 58
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 58
A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy (vol 29, pg 277, 2016) 58
Cardiovascular Risk after Kidney Transplantation: Causes and Current Approaches to a Relevant Burden 57
Autosomal Dominant Polycystic Kidney Disease: Is There a Role for Autophagy? 57
Nephrotic syndrome: pathophysiology and consequences 57
Immunosuppressive and antiviral treatment of hepatitis C virus-associated glomerular disease: A long-term follow-up 57
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus 56
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update 56
Monoclonal gammopathy in lupus nephritis 53
Anti-neutrophil cytoplasmic antibody-associated vasculitis in kidney transplantation 53
Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review 52
Is per-protocol kidney biopsy required in lupus nephritis? 50
Prevalence and clinical significance of ANCA positivity in lupus nephritis: a case series of 116 patients and literature review 50
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome 50
Acid-base balance and respiratory response during biofiltration with polyacrylonitrile membrane 50
Prognostic factors and long-term outcome with anca-associated kidney vasculitis in childhood 50
Delayed Graft Function in Kidney Transplant: Risk Factors, Consequences and Prevention Strategies 50
Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology 49
Anti-C1Q monitoring predicts relapses of lupus nephritis 49
History of Preeclampsia in Patients Undergoing a Kidney Biopsy: A Biphasic, Multiple-Hit Pathogenic Hypothesis 49
Predictors of increase in chronicity index and of kidney function impairment at repeat biopsy in lupus nephritis 48
Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: Clinico-pathological characterization and outcome 48
Anti-glomerular basement membrane vasculitis 48
Acute post-bacterial glomerulonephritis in renal transplant patients: Description of three cases and review of the literature 47
Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease 47
Long-term outcome of renal transplantation in adults with focal segmental glomerulosclerosis 47
C3 glomerulopathies: dense deposit disease and C3 glomerulonephritis 47
Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis 46
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence 46
Abnormalities of homocysteine and B vitamins in the nephrotic syndrome 46
A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy 45
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 44
Neutrophil Extracellular Traps in the Autoimmunity Context 43
Autophagy: A Silent Protagonist in Kidney Transplantation 43
Sirolimus plus prednisone for Erdheim-Chester disease: an open-label trial 43
Renal replacement therapy in sarcoidosis 43
Anti-C1q Autoantibodies in Lupus Nephritis 43
Lupus nephritis: When and how often to biopsy and what does it mean? 43
Old and new calcineurin inhibitors in lupus nephritis 43
Predictors of renal survival in ANCA-associated vasculitis. Validation of a histopathological classification schema and review of the literature 42
Idiopathic retroperitoneal fibrosis: Clinicopathologic features and differential diagnosis 42
Coexistence of Different Circulating Anti-Podocyte Antibodies in Membranous Nephropathy 41
Alport syndrome and pregnancy: a case series and literature review 41
Is preeclampsia a risk for end-stage renal disease? 41
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 41
Lupus nephritis: clinical presentations and outcomes in the 21st century 41
Acute renal failure in a single kidney with previous obstruction 40
Long-term prognosis of diffuse proliferative glomerulonephritis associated with infection in adults 40
Complement levels during the first trimester predict disease flare and adverse pregnancy outcomes in systemic lupus erythematosus: A network meta-analysis on 532 pregnancies 40
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 40
Rituximab monotherapy for remission induction of proliferative lupus nephritis flares: description of 3 cases 39
Progressive improvement of patient and renal survival and reduction of morbidity over time in patients with lupus nephritis (LN) followed for 20 years 39
Rituximab therapy for primary glomerulonephritis: Report on two cases 39
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 39
When and How Is It Possible to Stop Therapy in Patients with Lupus Nephritis: A Narrative Review 39
A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years 38
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 38
Are IF-ANA the guiding light for SLE classification in the real-world setting? 37
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 37
Renal disorders in rheumatologic diseases: the spectrum is changing (part 2. Arthridides) 37
Thin Basement Membrane: An Underrated Cause of End-Stage Renal Disease 37
Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up 37
Treatment of membranous lupus nephritis 37
Does pregnancy have any impact on long term damage accrual and on the outcome of lupus nephritis? 37
Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients 37
The long-term outcome of 93 patients with proliferative lupus nephritis 36
Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis 36
Immunosuppression in pregnant women with systemic lupus erythematosus 36
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 36
Clinical-Pathological Characteristics of Renal Injuries Identify Different Clusters in Patients With Antiphospholipid Antibodies 36
Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus? 36
The impact of recurrence of primary glomerulonephritis on renal allograft outcome 36
Chronic kidney disease, female infertility, and medically assisted reproduction: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology 36
The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival 36
Laser capture microdissection on formalin-fixed and paraffin-embedded renal transplanted biopsies: Technical perspectives for clinical practice application 35
The Impact of Preeclampsia in Lupus Nephritis 35
Renal disorders in rheumatologic diseases: the spectrum is changing (Part 1: connective tissue diseases) 35
Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient) 35
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis 35
Remission in systemic lupus erythematosus: testing different definitions in a large multicentre cohort 35
Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis 35
Treatment of dyslipidemia in kidney transplantation 35
Pregnancy after lupus nephritis 35
Ribavirin as a beneficial treatment option for hepatitis C virusassociated glomerular disease 35
Pregnancy in lupus nephritis 34
Totale 4.675
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.573
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.573
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 0 0 6 0 6
2021/202220 1 0 0 4 2 2 1 3 0 2 4 1
2022/202370 7 2 5 7 4 4 2 4 6 5 4 20
2023/2024267 33 12 47 20 14 41 33 10 4 2 17 34
2024/20252.218 12 97 65 14 17 236 137 173 267 603 294 303
2025/20265.358 825 392 331 682 224 360 1.443 388 384 329 0 0
Totale 7.973